Will a clinical trial reporting weight-loss benefits of a GLP-1 agonist be published in a major medical journal in 2024? | Manifold

Will a clinical trial reporting weight-loss benefits of a GLP-1 agonist be published in a major medical journal in 2024?

Plus

16

Ṁ1142

resolved Jan 7

Resolved

YES

1D

1W

1M

ALL

The rise of GPL-1 agonists as "miracle" drugs to cure obesity, hypertension, and a myriad of social issues related to an unhealthy body mass has been nothing short of stunning -- as important as the development of AI. But we are just learning about the other potential effects of these. Will a new clinical trial at least confirm what we think we know about this class of drugs?

This question is managed and resolved by Manifold.

#Weight loss drugs

Get

1,000

and

3.00

Sort by:

I'm double-checking medical journals this week. It's not as straightforward as you might think. One of the two studies linked below was not published in 2024 but in 2023. Have a bit more patience, please. (Not inactive, Paper, just traveling.)

@MikeLewis sorry! I get impatient too often (a bad habit). Thank you!

@MikeLewis how will this resolve?

[deleted]

https://link.springer.com/article/10.1007/s00125-023-06053-9

https://www.sciencedirect.com/science/article/pii/S0168827824023626

sold Ṁ85 NO

@JaimeSantaCruz yeah I think this is good enough evidence for yes

Related questions

Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?

Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027

Will there be medical consensus that GLP-1 drugs have cardiovascular benefits beyond those provided via weight loss?

Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?

Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?

Before 2033, will semaglutide be shown to improve lifespan, when prescribed to overweight people?

Will a drug company pay >$1m in a class action suit based on their statements about their GLP1 inhibitor by 2026?

[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...

Will Retatrutide (new obesity drug) be FDA approved by the end of 2025?

What fraction of US adults will regularly take GLP-1 drugs in 2030?

Related questions

Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?

Before 2033, will semaglutide be shown to improve lifespan, when prescribed to overweight people?

Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027

Will a drug company pay >$1m in a class action suit based on their statements about their GLP1 inhibitor by 2026?

Will there be medical consensus that GLP-1 drugs have cardiovascular benefits beyond those provided via weight loss?

[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...

Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?

Will Retatrutide (new obesity drug) be FDA approved by the end of 2025?

Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?

What fraction of US adults will regularly take GLP-1 drugs in 2030?

© Manifold Markets, Inc.•Terms + Mana-only Terms•Privacy•Rules